Skip to main content

Featured

DoJ rejects malicious attacks

The Department of Justice (DoJ) today said it will not tolerate malicious attacks on its decision, which was made in accordance with the law.   In a statement setting out the general principles in handling prosecutions, the DoJ reminded the public to refrain from commenting on any case in which the legal proceedings are still ongoing.   The statement said in respect of an application for review of admission to bail lodged by the DoJ on March 4, it should be noted that the case in question involves application for bail under Article 42(2) of the National Security Law.   The Court of Final Appeal delivered a judgment on February 9 on how to apply the granting of bail to a person charged with an offence under the National Security Law.   According to the Criminal Procedure Ordinance, the Secretary for Justice may apply to a judge to review the decision of admission to bail by a magistrate. The ordinance provides that a person may also apply to a judge to be admitted to bail if the

Govt responds to vaccine reports

The Department of Health has been actively following up with Sinovac Biotech (Hong Kong) to obtain relevant information of its vaccine to commence approval procedures as soon as possible.   The Government made the statement in response to media reports on the submission of phase 3 clinical data of Sinovac’s vaccine to the Department of Health.   In accordance with the guidance of the Advisory Panel on COVID-19 Vaccines, the Department of Health had previously requested Sinovac to have the relevant clinical data published in medical journals.   However, Sinovac indicated that it has considerable difficulties compiling the relevant information for publication in a short period. Having regard to the urgency for vaccination, the department has requested Sinovac to provide its phase 3 clinical data submitted to the World Health Organization (WHO) for assessment.   The Government stressed it did not set today as the deadline as reported in media reports.   Up till now, Sinovac has provided the Department of Health with its phase 1 and phase 2 clinical data submitted to the WHO and drug regulatory authorities of other jurisdictions, among other information.   Sinovac has also provided to the department a set of its phase 3 clinical data of trials conducted in Brazil that it had submitted to drug regulatory authorities of other jurisdictions.   Furthermore, Sinovac indicated that it could provide to the department as early as this week the phase 3 clinical information of its trials conducted in Brazil and Turkey, etc that it submitted to the WHO.   After compilation of all the information, the Department of Health will submit the documents to the advisory panel next week for review and arrange a meeting for the panel to assess and put up a recommendation as soon as possible to make sure the relevant vaccine satisfies the criteria of safety, efficacy and quality.    The Government added it will continue to adhere to the principles of openness and transparency so that the public can obtain the latest information on vaccines.
http://dlvr.it/Rs9qfb

Popular Posts